P. Bruggmann, “Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030”, Swiss Med Wkly, vol. 147, no. 4546, p. w14543, Nov. 2017.